Borenius advised Teva Pharmaceuticals on the case. Teva Pharmaceuticals partecipated in a patent dispute before the Finnish Market Court concerning Bristol-Myers Squibb Holdings Ireland Unlimited Company’s...
Teva Pharmaceuticals’ Patent Dispute
Teva Pharmaceuticals’ Licensing Agreement with mAbxience
Ropes & Gray represented Teva Pharmaceuticals International GmbH in the deal. Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced...
Teva Pharmaceutical’s Bonds Offering
Baker McKenzie advised the syndicate of 10 underwriters on the deal. Teva Pharmaceutical Industries Limited executed a multi-tranche USD 2.5 billion (equivalent) (upsized from USD 2.06 billion)...
Teva v. Novartis
Pinsent Masons represented Teva in the dispute, while Bristows represented Novartis. Teva brought revocation proceedings against two Novartis patents concerning deferasirox, EP 29 64 202 and...
Teva Pharmaceutical’s $5 Billion Sustainability-Linked Bond Offering
Kirkland advised Teva, while Baker McKenzie and Herzog, Fox & Neeman advised the underwriters on the offering. Teva Pharmaceutical Industries Limited executed a $5 billion (equivalent) (upsized...
MODAG’s Collaboration Agreement with Teva
Baker McKenzie advised Modag GmbH on the deal. Blomstein advised Teva Pharmaceutical Industries Limited. MODAG GmbH signed a collaboration agreement with Teva Pharmaceutical Industries Ltd. on the exclusive...